Boehringer Ingelheim Pharmaceuticals Inc. v. Sun Pharmaceutical Industries Limited et al
| Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation |
| Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. and Ohm Laboratories, Inc. |
| 1:2021cv01487 |
| October 22, 2021 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 30, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re #9 STIPULATION TO EXTEND TIME, filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited. Reset Answer Deadlines: Ohm Laboratories, Inc. answer due 1/18/2022; Sun Pharmaceutical Industries Limited answer due 1/18/2022; Sun Pharmaceutical Industries, Inc. answer due 1/18/2022. Ordered by Judge Colm F. Connolly on 11/30/2021. (kmd)
|
| Filing 9 STIPULATION TO EXTEND TIME Various to See Stipulation - filed by Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Bilson, David) |
| Filing 8 SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries, Inc. served on 11/11/2021, answer due 12/2/2021. (Dellinger, Megan) |
| Filing 7 SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries Limited served on 11/11/2021, answer due 12/2/2021. (Dellinger, Megan) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-01485-CFC, 1:21-cv-01486-CFC, 1:21-cv-01487-CFC (rjb) |
| Filing 6 Summons Issued with Magistrate Consent Notice attached as to Ohm Laboratories, Inc. on 10/22/2021; Sun Pharmaceutical Industries Limited on 10/22/2021; Sun Pharmaceutical Industries, Inc. on 10/22/2021. (Attachments: #1 Summons Issued, #2 Summons Issued)(apk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (apk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,090,323 B2. (apk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/24/2021. Date of Expiration of Patent: 04/3/2034. (apk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Filing 1 COMPLAINT filed against Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3727473.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
